New brain research could reshape our understanding of ADHD and the most common drugs that treat it.

The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.

The FDA has accepted Otsuka’s New Drug Application for centanafadine, a first-in-class norepinephrine, dopamine and serotonin reuptake inhibitor (NDSRI) for the treatment of attention-deficit ...

With an expiration date still more than a year away, here's what the latest details reveal.

It has long been assumed that psychostimulants help those with ADHD by acting on the brain’s attention circuitry. However, ...

From February 1, GPs and nurse practitioners will be able to diagnose people with ADHD and prescribe them medication.

From 2022 to 2024, stimulant prescriptions issued in Connecticut increased by 13.2 percent, according to data from the state.

Women with ADHD are often diagnosed late due to masking, hormonal changes, and outdated stereotypes. Learn why ADHD in women is missed for years and how better awareness can change lives.

This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: ADHD and menopause symptoms can overlap, and one ...

ADHD is associated with impulsivity, hyperactivity, and trouble with focus, but kids with ADHD may also struggle with motor ...